云南白药

- 000538

-

-  -

-
昨收盘:- 今开盘:- 最高价:- 最低价:-
市值:-亿元 流通:- 成交:-手 换手:-
历年数据:  2024  2023  2022  2021  2020  2019  2018  2017  2016  2015  2014 
云南白药(000538) 利润表
单位:万元
报表日期2024-03-312023-12-312023-09-302023-06-302023-03-31
一、营业总收入1,077,429.093,911,129.222,968,853.212,030,937.291,051,275.10
营业收入1,077,429.093,911,129.222,968,853.212,030,937.291,051,275.10
二、营业总成本898,442.063,508,274.992,565,534.641,746,256.68907,960.23
营业成本754,446.722,874,451.762,156,176.681,471,323.23763,014.26
营业税金及附加5,509.3121,080.1515,667.9810,837.284,790.58
销售费用123,336.23499,215.76335,409.25225,768.85120,076.17
管理费用16,143.73105,850.3555,544.7134,444.3816,447.50
财务费用-6,722.15-25,924.37-19,124.58-10,599.06-2,776.87
研发费用5,728.2133,601.3421,860.6014,481.996,408.59
资产减值损失----------
公允价值变动收益-1,952.3312,356.6310,364.715,308.8910,315.21
投资收益24,422.6177,901.0770,322.3542,154.2224,239.90
其中:对联营企业和合营企业的投资收益26,635.0562,853.1564,856.7044,704.8926,721.07
汇兑收益----------
三、营业利润191,801.99483,050.61487,337.72331,334.54173,018.07
加:营业外收入233.201,223.40567.67200.27263.66
减:营业外支出65.762,472.841,529.071,206.85566.42
其中:非流动资产处置损失----------
四、利润总额191,969.43481,801.18486,376.33330,327.97172,715.31
减:所得税费用22,064.7969,545.0774,125.7347,702.0821,142.96
五、净利润169,904.64412,256.11412,250.60282,625.88151,572.35
归属于母公司所有者的净利润170,193.14409,378.21412,347.74282,801.16151,798.84
少数股东损益-288.502,877.90-97.14-175.28-226.49
六、每股收益
基本每股收益(元/股)0.95002.29002.31001.58000.8500
稀释每股收益(元/股)0.95002.29002.30001.58000.8500
七、其他综合收益-96.29-2,184.78-2,775.64-2,874.94656.16
八、综合收益总额169,808.35410,071.33409,474.96279,750.94152,228.51
归属于母公司所有者的综合收益总额170,092.21407,233.16409,140.02280,047.43152,277.41
归属于少数股东的综合收益总额-283.862,838.17334.94-296.49-48.91
下载全部历史数据到excel中 返回页顶